A potential target for liver cancer management, lysophosphatidic acid receptor 6 (LPAR6), is transcriptionally up-regulated by the NCOA3 coactivator. [electronic resource]
Producer: 20201014Description: 1474-1488 p. digitalISSN:- 1083-351X
- Animals
- Cell Proliferation -- drug effects
- Gene Expression Regulation, Neoplastic -- drug effects
- Hep G2 Cells
- Hepatocyte Growth Factor -- therapeutic use
- Humans
- Liver Neoplasms -- drug therapy
- Male
- Mice, Inbred BALB C
- Mice, Nude
- Mice, SCID
- Nuclear Receptor Coactivator 3 -- genetics
- Receptors, Lysophosphatidic Acid -- genetics
- Up-Regulation -- drug effects
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.